Silke is co-founder and chief scientific officer of the NGS diagnostics company Noscendo where she leads the laboratory and lab R&D activities to make metagenomic NGS available to clinics in Europe. Her special interest is cell-free DNA in infectious disease. She’s been working in this field since gaining her PhD in 2013 in applied research in infectious disease